Using an antibody targeting IGFBP7 in a mouse model of psoriasis, Li, Shao, and authors demonstrated that antibody-mediated blockade of IGFBP7 may be a feasible therapeutic strategy in the management of psoriasis that targets an alternative immunologic pathway: immune cell trafficking and transmigration (6). The gene discussed is IGFBP7; the disease is psoriasis.